Programme

Keywords
PDF version

Wed 23 Oct

10:00

e-poster session day 1

to
Digital kiosks
e-poster session

e-poster session day 1

to
Digital kiosks
e-poster session

e-poster session day 1

to
Digital kiosks
e-poster session

11:50

Cannabis legalisation in Canada and the US: policy variation, state of the evidence and ideas for future research

to
Auditorium I
Major session

Advances in drug treatment

to
Auditorium II
Oral presentation session

Advances in drug treatment

to
Auditorium II
Oral presentation session

Innovative health approaches

to
Auditorium III
Oral presentation session

Sex, gender and diversity in drugs

to
Auditorium IV
Oral presentation session

Advancing addiction research: global perspectives and collaborative initiatives

to
Auditorium VI
Oral presentation session

Advancing addiction research: global perspectives and collaborative initiatives

to
Auditorium VI
Oral presentation session

Lives at risk: mental health and substance use

to
Auditorium VII
Oral presentation session

Prevalence of opioids and related harms

to
Auditorium VIII
Oral presentation session

Gambling: work-related, financial, and criminological issues

to
Room 5B
Oral presentation session

Building addiction workforce capacity

to
Room 5C
Oral presentation session

14:20

Neuroscience and cognition

to
Auditorium III
Short communication session

Neuroscience and cognition

to
Auditorium III
Short communication session

Neuroscience and cognition

to
Auditorium III
Short communication session

Legal shifts and their Impact on drug use and sentencing

to
Auditorium IV
Oral presentation session

Drug policy and the criminal legal system

to
Auditorium VI
Oral presentation session

Gender and substance use

to
Auditorium VIII
Oral presentation session

Neurocognitive processes in behavioural addictions

to
Room 5B
Oral presentation session

Alcohol use disorder: clinical biology and epidemiology

to
Room 1.05
Short communication session

Challenge of measuring use and impact of cannabinoids

to
Room 1.07
Oral presentation session

Methods and measurement

to
Room 1.08
Short communication session

16:00

Infectious diseases in people who inject drugs

to
Auditorium IV
Oral presentation session

Measuring drug market phenomenon

to
Auditorium VI
Oral presentation session

Substance use and psychosis

to
Auditorium VII
Oral presentation session

Responses to behavioural addictions

to
Room 1.05
Short communication session

Problematic gambling and gaming

to
Room 1.07
Short communication session

Conceptualising health and harms

to
Room 1.08
Short communication session

17:50

The EUFAS-EAR European Addiction Research Award

to
Auditorium I
Major session

NPS: trends, concerns and response strategies

to
Auditorium III
Oral presentation session

NPS: trends, concerns and response strategies

to
Auditorium III
Oral presentation session

Decriminalisation and alternatives to arrest

to
Auditorium VI
Oral presentation session

Understanding interrelationships: mental health and substance use

to
Auditorium VII
Oral presentation session

Psychedelics 1

to
Auditorium VIII
Oral presentation session

Novel and contextual approaches in prevention

to
Room 5A
Oral presentation session

Hepatitis C, HIV, and other drug related harms

to
Room 1.05
Short communication session

Hepatitis C, HIV, and other drug related harms

to
Room 1.05
Short communication session

Opioids: trends, use and treatments

to
Room 1.06
Short communication session

Opioids: trends, use and treatments

to
Room 1.06
Short communication session

Capacity-building through competencies for the substance use workforce

to
Room 1.10
Workshop

Thu 24 Oct

11:50

Predicting the future: biomarkers for progression of alcohol use disorder

to
Auditorium II
Oral presentation session

Opioid treatment 2

to
Auditorium III
Oral presentation session

Opioid Agonist Treatment: novel formulations and challenges

to
Auditorium IV
Oral presentation session

Evidence informed drug and alcohol policy

to
Auditorium VI
Oral presentation session

Emerging drug harms, DCRs and other responses

to
Auditorium VII
Short communication session

Natural language processing for addiction research: a practical primer

to
Room 1.06
Workshop

14:20

Novel neurobiology - cannabis, cognition and craving

to
Auditorium III
Oral presentation session

Understanding drug-related deaths

to
Auditorium IV
Oral presentation session

Young people, mental health and substance use

to
Auditorium VII
Oral presentation session

Co-creating robust systems with workers

to
Room 5C
Oral presentation session

Co-creating robust systems with workers

to
Room 5C
Oral presentation session

Co-creating robust systems with workers

to
Room 5C
Oral presentation session

Understanding harm reduction: economic, social, and health perspectives

to
Room 1.05
Short communication session

Women's realities of drug use

to
Room 1.08
Oral presentation session

16:00

NPS: Pharmacological Characterization and Substance Analysis

to
Auditorium III
Oral presentation session

Cannabis legalisation — models and impacts

to
Auditorium VI
Oral presentation session

Cannabis legalisation — models and impacts

to
Auditorium VI
Oral presentation session

From genes to brains

to
Room 1.06
Short communication session

17:50

Misuse of medicines

to
Auditorium VIII
Oral presentation session

New Research on Alcohol and Tobacco Policy

to
Room 5A
Oral presentation session

From old to new: changes in drug use

to
Room 5C
Oral presentation session

Behavioural addictions, prevention and theory

to
Room 1.05
Short communication session

Newly Regulated Markets, Managing Harms, Treatment & Advocating for Reform

to
Room 1.06
Short communication session

Fri 25 Oct

11:50

Psychedelics 2

to
Auditorium VI
Oral presentation session

Trauma and substance use

to
Auditorium VII
Oral presentation session

Trauma and substance use

to
Auditorium VII
Oral presentation session

Drugs checking services

to
Room 5A
Oral presentation session

Drugs checking services

to
Room 5A
Oral presentation session

Emerging challenges in drug markets: monitoring, measurement & impacts

to
Room 1.05
Short communication session

Gaming and health

to
Room 1.06
Short communication session

Gaming and health

to
Room 1.06
Short communication session

How can cannabis policy goals inform the development of evaluation indicators?

to
Room 1.08
Workshop

14:20

Addressing diverse treatment needs

to
Auditorium VI
Oral presentation session

Prevention and addiction in underrepresented groups

to
Room 5A
Oral presentation session

16:00

Novel psychoactive substances and latest drug trends in Asia and Pacific countries

to
Room 1.05
Oral presentation session